PET/MR for evaluation of musculoskeletal malignancies

ConclusionsDespite limited evidence and the lack of widespread application, PET/MR is a promising imaging technique for evaluating musculoskeletal malignancies. This is owing primarily to the strength of its constituent modalities. PET permits for acquisition of metabolic information using a variety of emerging novel radiopharmaceuticals. MR allows for assessment of bone marrow and for identification and characterization of soft-tissue lesions. Selection of appropriate radiopharmaceutical and MR protocol parameters is key for optimal evaluation. Although PET/MR has shown promise in evaluation of musculoskeletal involvement of multiple malignancies, it has not yet demonstrated broad superior to PET/CT. More research is needed to understand its value in the care of patients with such diseases.
Source: Clinical and Translational Imaging - Category: Radiology Source Type: research